Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Oncotarget
Raaijmakers, Marieke I G MI; Widmer, Daniel S DS; Narechania, Apurva A; Eichhoff, Ossia O; Freiberger, Sandra N SN; Wenzina, Judith J; Cheng, Phil F PF; Mihic-Probst, Daniela D; Desalle, Rob R; Dummer, Reinhard R; Levesque, Mitchell P MP
G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA.
Nucleic Acids Research
Giri, Banabihari B; Smaldino, Philip J PJ; Thys, Ryan G RG; Creacy, Steven D SD; Routh, Eric D ED; Hantgan, Roy R RR; Lattmann, Simon S; Nagamine, Yoshikuni Y; Akman, Steven A SA; Vaughn, James P JP